In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus Asunaprevir

INTRODUCTION: Daclatasvir is a non-structural protein 5A (NS5A) inhibitor with activity against hepatitis C virus (HCV) genotypes 1–6 in vitro, and asunaprevir is a non-structural protein 3 (NS3) protease inhibitor with activity against genotypes 1, 4, 5, and 6. This study evaluates potential option...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Infect Dis Ther
Egile Nagusiak: Friborg, Jacques, Zhou, Nannan, Han, Zhou, Yang, Xiaoyan, Falk, Paul, Mendez, Patricia, McPhee, Fiona
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2014
Gaiak:
Brief Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363215/
https://ncbi.nlm.nih.gov/pubmed/25516102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-014-0052-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak